DNA vaccination has been used to generate effective cellular as well as humoral immunity against target antigens. Here we have investigated the induction and involvement of regulatory T cell (T reg ) responses in mediating prevention of experimental autoimmune encephalomyelitis (EAE), following vaccination with plasmid DNA encoding the TCR V β 8.2 chain predominantly displayed on diseasecausing lymphocytes. Vaccination with DNA encoding the wild-type TCR results in priming of type 1 CD4 T reg and skewing of the global response to myelin basic protein in a T h 2 direction, leading to significant protection from disease. In contrast, vaccination with mutant DNA encoding altered residues critically involved in recognition by the T reg results in priming of a type 2 regulatory response which fails to mediate immune deviation or protection from EAE. Control mice immunized with DNA, encoding TCR with changes at an irrelevant site, were protected from antigen-induced disease. Furthermore, protection can be transferred into naive recipients with CD4 T reg from wildtype DNA-immunized mice but not from animals vaccinated with the mutant DNA. These data suggest that vaccination with plasmid DNA encoding one or multiple V β genes can be exploited to enhance natural regulatory responses for intervention in autoimmune conditions.
Introduction
Immunization with plasmid DNA encoding a protein antigen CpG motifs that activate APC, e.g. dendritic cells (DC), resulting in secretion of IL-12. The bone marrow-derived DC results in effective and long-lasting cellular and humoral immunity in several antigenic systems (1,2). Such DNA immuncould potentially get transfected with the DNA, and directly process and present the encoded antigen (9-11). Alternatization can evoke both CD8 and CD4 T cell responses mediated by presentation of antigenic determinants in the ively, DC could cross-prime T cells after acquiring antigenic protein from other cell types; data supporting both routes of context of class I and class II MHC molecules respectively (3-5). The intramuscular delivery of DNA generally induces an antigen presentation by DC have been reported. In rodents, DNA vaccines have been shown to induce protective, cellantigen-reactive, proinflammatory type 1 CD4 T cell response, through the activation and processing and presentation of mediated immunity against organisms such as Leishmaniasis major, Mycobacterium tuberculosis, and conditions such as antigen by bone marrow-derived professional antigen-presenting cells (APC) (6-8). The plasmid vector also contains malaria, tumors and allergen-induced anaphylaxis (1,2). A recent report of the induction of cellular immune responses immunostimulatory nucleotide sequences-unmethylated to a peptide of Plasmodium falciparum in humans by a DNA PstI (site overlapping codons 2-4 of the mature gene)-BstEII (site 5Ј to c-myc tag fragments). pCMV8 has a PstI site in the vaccine raises hopes for the clinical applicability of this method of immunization (12) .
polylinker proximal to the 5Ј end of the V β gene and this cloning therefore resulted in the loss of~25 bases of coding Experimental autoimmune encephalomyelitis (EAE) is a prototypic CD4 T cell-mediated autoimmune disease model sequence. Following PstI digestion, this sequence was ligated into the construct as an oligonucleotide duplex to reconstitute for the human demyelinating disease multiple sclerosis (13) . It is characterized by inflammation and demyelination in the the complete coding sequence. The V β 3 construct, containing the V β domain gene derived from the 2B4 hybridoma (a central nervous system accompanied by paralysis following immunization with myelin antigens, e.g. myelin basic protein generous gift of Dr Mark Davis, Stanford University), was made in an analogous way to the wild-type V β 8.2 construct. (MBP). A majority of the MBP-primed effector CD4 T cells which mediate EAE in H-2 u mice recognize the N-terminal
The inserts of all constructs were sequenced prior to use. All constructs were transiently transfected into COS cells and a peptide MBPAc1-9 or Ac1-20 and predominantly use the TCR V β 8.2 gene segment (14,15). Although the regulation and similar level of expression of V β -myc protein was verified by analysis of cell lysates on immunoblots using the anti-c-myc function of individual cytokines is complex, most experimental observations are consistent with the idea that myelin antigenantibody 9E10 as described previously (36). specific T h 1 cells are encephalitogenic, whereas a T h 2
Plasmid DNA vaccination response is protective (16, 17) .
Recently, vaccination with TCR V β 8.2 plasmid DNA has The purified plasmid DNA samples were dissolved in PBS. DNA (100 µg) was injected 2-3 times intramuscularly at been shown to result in significant protection from subsequent induction of antigen-induced EAE (18) . However, the mechanweekly intervals. One week following the last injection of DNA, mice were s.c. immunized with MBPAc1-9/complete Freund's ism or the involvement of a regulatory T cell (T reg ) response in the prevention of disease has not yet been defined. adjuvant (CFA) for the induction of EAE. Furthermore, it has not been described how intramuscular Mice V β 8.2 DNA immunization that predominantly induces CD4 T h 1 cells results in deviating the response to MBP in a protective B10.PL and SJL/J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). (SJLϫB10.PL)F 1 mice were T h 2 direction. Here we have examined whether DNA vaccination can prime an appropriate T reg response that controls EAE bred under specific pathogen-free conditions in our colony. Female B10.PL or (SJLϫB10.PL)F 1 mice, as indicated in the (19) . Using mutant V β 8 DNA molecules and cell transfer strategies, we demonstrate that T reg reactive to the TCR text or in legends for the figures and tables, were generally used at 10-14 weeks of age, and were maintained on standard peptide B5 (amino acids 76-101) containing the framework region (FR) 3 determinant are involved in mediating skewing laboratory diet and water ad libitum in specific pathogen-free animal facilities at UCLA and LIAI. of the anti-MBP response in a protective type 2 direction and prevention of disease. These findings have important TCR peptides implications for preventive or therapeutic vaccine approaches for T cell-mediated pathological conditions.
The TCR V β 8.2 peptides used were the same as reported previously (19) : B1, amino acids 1-30L (TCR FR1 region peptide); B4, amino acids 61-90; B5, amino acids 76-101 Methods (TCR FR3 region peptide).
Construction of plasmid DNA Measurement of antigen-specific proliferative responses
Proliferative responses to MBPAc1-9 or Ac1-20 and TCR The plasmids for genetic vaccination were made as follows: for the V β 8.2 construct, a plasmid containing the V β domain peptides were determined in lymph nodes or spleens essentially as described earlier (19) . To monitor priming of CD4 gene (V β -D β -J β ) with a C-terminal c-myc epitope has been described previously (36). A 5Ј EcoRI site followed by an in-T reg , spleens were removed 7-10 days after the last plasmid DNA injection. Lymph node cells (4ϫ10 5 cells/well) and frame methionine codon were appended to the 5Ј end of the gene encoding the mature V β domain using the PCR and the splenocytes (8ϫ10 5 cells/well) were cultured in 96-well microtiter plates in 200 µl of serum-free medium (HL-1; Ventrex, following oligonucleotide primer: 5Ј-ATC AGA ATT CAT GGA GGC TGC AGT CAC CCA A-3Ј. The 3Ј end of the gene (i.e.
Portland, ME/X-vivo 10; BioWhittaker, Walkersville, MD) supplemented with 2 mM glutamine; peptides were added at the c-myc epitope tag) was tailored with a BamHI site using the PCR and the primer: 5Ј-TGA TGG ATC CTT ATT AGA concentrations ranging from 0.1 to 7 µM final concentration. Proliferation was assayed by addition of 1 µCi [ 3 H]thymidine GAA CAG TCA GTC TGG T-3Ј. The gene was initially cloned into the vector pCMV5 as an EcoRI-BamHI fragment and (ICN, Irvine, CA) for the last 18 h of a 5-day culture and incorporation of label was measured by liquid scintillation then subsequently ligated into pCMV8 (a derivative of pCMV5 with an additional leader intron which expresses higher levels counting. of protein) as a SalI-BamHI fragment. Mutated variants of the Induction and clinical evaluation of EAE V β 8.2 gene were generated by site-directed mutagenesis (37) (Q85A, V88A and F90A, where Q85A indicates mutation of Mice were immunized s.c. with 100 µg of guinea pig MBP or Ac1-9 or its high-affinity variant (9.4Met) emulsified in CFA; Gln85 to alanine, etc.) or splicing by overlap extension (38) (V10A, V12S and L107A). These mutated V β genes were then 0.15 µg pertussis toxin (PT) (List Biological, Campbell, CA) was injected in 200 µl saline i.v. 48 h later. Mice were observed used to replace the wild-type region of the V β 8.2 gene as irr DNA encode for alterations in the FR3 region (Q85A, V88A and (four or five each) were immunized intramuscularly with 100 µg of F90A) and an irrelevant region (V10A, V12S and L107A) of the V β 8.2 plasmid DNAs (V β 8.2wt, V β 8.2mut-rel, V β 3 or PBS) 3 times at weekly chain respectively. intervals. One week after the last DNA injection, animals were injected with MBPAc1-9/CFA/PT for the induction of EAE. The clinical symptoms of EAE were monitored and scored daily, as described in Methods.
ated with the V β 8.2 DNA were significantly protected from disease. In the V β 8-vaccinated group only three out of 12 mice developed mild paralysis and recovered quickly (duration of daily for signs of EAE until 40-60 days after immunization.
disease ranged from 4 to 8 days). In contrast, all animals in The average disease score for each group was calculated the PBS or the V β 3 DNA vaccinated group contracted severe by averaging the maximum severity for all of the affected EAE (duration of disease ranged from 9 to 20 days). Data animals in the group. Disease severity was scored on a fivefrom two different experiments are summarized in Table 1 . point scale, as described earlier (19) : 1, flaccid tail; 2, hind The levels of expression of different DNA constructs were limb weakness; 3, hind limb paralysis; 4, hind and front limb found to be similar (see Methods). or whole body paralysis; 5, moribund or death.
Vaccination with mutant V β 8.2 DNA encoding altered residues Measurement of lymphokine secretion in the FR3 region recognized by T reg does not prevent EAE The frequency of antigen-induced IFN-γ-or IL-4-producing T
We have shown earlier that CD4 T reg reactive to the dominant cells was determined using the sensitive, single-cell ELISA-FR3 region of the V β 8.2 chain (peptide 'B5', amino acids spot assay or ELISA, as described earlier (39) . For ELISA-76-101/A u , also referred to as the TCR FR3 peptide) are spot assays, after culture of lymph node or splenic cells with spontaneously primed in B10.PL mice following MBP injection antigen for 48 h, live cells were recovered, washed and and mediate recovery from EAE (19, 20) . We asked whether transferred by serial dilution (from 10 4 to 5ϫ10 5 cells/well) to TCR peptide B5-reactive T reg expanded following DNA vac-96-well microtiter plates (Millipore, Bedford, MA) that had been cination. Ten days following the last DNA challenge, proliferatprecoated with the capturing mAb (anti-IFN-γ or anti-IL-4) at ive recall responses to B5 peptide in draining lymph node 2 mg/ml. After 24 h, cells were removed, and spots were cells isolated from PBS-, V β 3-or V β 8.2 DNA-immunized mice visualized using biotinylated detecting mAb and avidin were examined. Stimulation indices (SI) in the V β 8.2 group D-peroxidase in conjunction with 3-amino-9-ethylcarbazole ranged from 6.1 to 17.4 in comparison to 1.6 to 2.7 in the two (Sigma, St Louis, MO) substrate. Spots were counted under control groups. There was no proliferative response to another a dissecting microscope, and the frequency of antigen-V β 8.2-derived peptide, B1 (amino acids 1-30L), in any of the specific cells was determined from the difference between vaccinated animals. To determine the cytokine phenotype of the number of spots seen with and without antigen. All T reg , secretion of IL-4 or IFN-γ was determined in the culture capturing and detecting antibody pairs were purchased from supernatants. IFN-γ production in response to B5 was~4-fold PharMingen (San Diego, CA).
higher (average 912 pg/ml) in the V β 8.2 DNA-immunized group versus V β 3-or PBS-treated controls (230 pg/ml). There was no detectable level of IL-4 in cultures from any of the Results groups. These data suggest that processing and presentation V β 8.2wt DNA vaccination protects B10.PL mice from antigenof the FR3 region determinant of the V β 8.2 chain following induced EAE DNA vaccination results in expansion of B5-reactive type 1 T reg in vivo. B10.PL mice were immunized 2-3 times at weekly intervals intramuscularly with plasmid DNA encoding the V β 8.2wt gene
Having established the expansion of T reg , we next examined whether these cells directly participate in the DNA-induced in PBS. In parallel, mice were also vaccinated with an irrelevant plasmid DNA encoding the V β 3 gene or with PBS. One week protection from disease. To test this notion, mutated V β 8.2 plasmid DNA was created and used for vaccination. In the following the last DNA injection, animals were challenged with MBPAc1-9/CFA/PT for the induction of EAE and monitored first instance, mutations were introduced in a relevant region, V β 8.2mut-rel, to change three critical residues (Q85, V88 and daily for clinical symptoms. As shown in Fig. 1 , mice vaccin- last DNA challenge, mice (three in each group) were s.c. B1 in any of the groups of mice. A similar proliferative response (SI ϭ 2.6-5.3) to peptide B5 was detected in all three groups of mice immunized with the V β 8.2wt, V β 8.2mut-rel or V β 8.2mut-irr DNA plasmids (Fig. 2) . In contrast, there was F90) involved in the recognition of FR3 peptide by T reg (21) . In parallel, another mutant DNA (V β 8.2mut-irr) was made no significant response (SI Ͻ 2) to B5 in the PBS-or the V β 3-immunized animals. Interestingly, while the T reg response was encoding three altered residues (A10, S12 and L107) in an irrelevant portion of the V β 8.2 chain that is not involved in T h 1-like in animals immunized with either the V β 8.2wt or the V β 8.2mut-irr, mice vaccinated with the V β 8.2mut-rel DNA recognition by T reg but juxtaposed on the TCR. As shown in Fig. 1 and Table 1 , mice vaccinated with the V β 8.2mut-rel showed a predominantly T h 2-like response (Fig. 2) . In all groups proliferative responses to Ac1-20 were similar, with DNA encoding changes in the FR3 determinant region are not protected from EAE. In contrast, animals vaccinated with SI ϭ 6.3 to 9.1. However, as shown in Fig. 2 , the frequencies of IL-4-or IFN-γ-secreting Ac1-20-reactive T cells were quite the V β 8.2mut-irr DNA are significantly protected from disease (see Table 1 ). Interestingly, mice vaccinated with V β 8.2-mut-rel different: a T h 1-predominant response correlated with susceptibility to EAE, whereas T h 2-like responses were dominant in DNA contracted more severe disease in comparison to mice in the other control groups: seven out of 10 animals died protected mice. Thus, following V β 8.2wt or V β 8.2mut-irr, the response to Ac1-20 was deviated in a T h 2 direction. In following severe paralysis in this group. These data suggest that the FR3 region determinant represents a crucial target for contrast, in other groups the frequency of Ac1-20-reactive T cells secreting IFN-γ was much higher than the cells secreting the induction of regulation of EAE following DNA vaccination.
IL-4, representing a T h 1-like response. The frequency of IFN-CD4 T reg reactive to the FR3 region of the V β 8.2 chain mediate γ-or IL-4-secreting cells in response to PPD did not vary protection from EAE significantly in any of the groups (data not shown). These data indicate that type 1 T reg are required to deviate the MBPAlthough data presented above suggest that FR3 peptidereactive T reg are involved in regulation, it was still possible reactive response in a T h 2 direction and are consistent with our recent experiments using mucosal priming with TCR that mutation in the FR3 region of the V β 8.2 chain altered both the T reg response as well as an anti-TCR humoral peptide B5 (17). response. To examine this possibility, we determined whether sera collected from DNA vaccinated mice from any of the Discussion groups (PBS, V β 3 or V β 8.2 immunized) contained anti-V β 8.2 antibodies. Contrary to the earlier suggestion (18) , using flow
The data presented here clearly demonstrate that vaccination of B10.PL mice with plasmid DNA encoding the TCR V β 8.2 cytometry analysis, we did not detect significant staining of V β 8.2 ϩ T cells with any of the sera tested (data not shown).
gene segment, predominantly expressed on MBP-reactive encephalitogenic T cells, results in significant protection To further examine the involvement of FR3 peptide-reactive T reg , CD4 T cells were isolated from mice vaccinated with from antigen-induced EAE. The protection is specific in that vaccination with DNA encoding the TCR V β 3 gene segment, V β 8.2wt, V β 8.2mut-rel, V β 8.2mut-irr or V β 3 DNA molecules. Following in vitro stimulation with the TCR peptide B5, purified not displayed on disease-causing T cells, does not influence the course of disease. Furthermore, the V β 8.2 DNA-mediated CD4 T cell populations were transferred into naive B10.PL mice. Recipients were challenged with MBPAc1-9/CFA/PT for protection involves type 1 CD4 T reg reactive with the dominant determinant from the FR3 region of the V β 8.2 chain. Thus, the induction of EAE. As shown in Table 2 , recipient animals which received T cells from mice vaccinated with V β 8.2wt or vaccination with V β 8.2mut-rel DNA encoding point mutations in the FR3 region, critical for recognition by T reg , does not V β 8.2mut-irr DNA molecules were significantly protected from disease. In contrast, recipients of T cells from control mice prevent EAE, whereas vaccination with the V β 8.2mut-irr DNA encoding alterations in an irrelevant region of the TCR chain vaccinated with either the V β 8.2mut-rel or V β 3 DNA are not is protective. Prevention of EAE is accompanied by deviation leading to exacerbation of disease and the death of most animals following paralysis. Thus, the encephalitogenic potenof the anti-MBPAc1-20 response in a T h 2 direction.
It is interesting that the in vivo processing and presentation tial of the MBP-reactive effector population is crucially and dominantly influenced by the cytokine secretion phenotype of the TCR V β 8.2 chain following DNA vaccination leads to priming/expansion of type 1 CD4 T cells reactive to the of CD4 T reg .
Although, a precise molecular mechanism of the eventual naturally processed, dominant determinant from the FR3 region. As proposed earlier (2,9-11), it is likely that profesdeviation of the anti-MBP response following the action of type 1 T reg is not yet clear, our data suggest that T reg indirectly sional APC, e.g. DC, process and present the TCR peptide to CD4 T reg resulting in their expansion. This is consistent influence cytokine predominance in the MBP-reactive T cell population (25) . The secretion of proinflammatory cytokines with the finding that T reg , primed following DNA vaccination, predominantly secrete inflammatory cytokines, such as IFNby CD4 T reg is required for efficient recruitment/activation of CD8 T reg reactive to another determinant, from the FR2/CDR2 γ. Indeed, we have recently demonstrated that type 1 T reg are required to deviate the anti-MBPAc1-20 response in a T h 2 region of the V β 8.2 chain. For example, secretion of these cytokines may result in up-regulation of co-stimulatory or direction (17, 22) . It is noteworthy that vaccination with the V β 8.2mut-rel DNA encoding relevant changes in the FR3 adhesion molecules on APC for an efficient induction of the CD8 population. Consistent with the involvement of a distinct region results in activation of type 2 T cells specific for TCR peptide B5 and exacerbation of disease. Thus the relevant CD8 T reg in this regulation, in preliminary experiments we found that mice vaccinated with the mutant V β 8.2 DNA mutant DNA apparently encodes an altered peptide ligand for the CD4 T reg resulting in their priming in a T h 2 direction encoding alterations in the FR2/CDR2 region were not protected from EAE. Recently, two different groups have demon- (23, 24) . In our preliminary experiments, in contrast to the wildtype FR3 region peptide, a mutated peptide containing such strated that CD4 T cell help via a class II MHC-dependent pathway is required for the efficient generation of an effective alterations does not prevent MBP-induced EAE. This is consistent with recent findings (17) 
